FDA Modernization Act 3.0
Introduced Apr 10, 2025 by Rep. Earl L. "Buddy" Carter
The House passed it. The Senate has to pass it before it can reach the President.
This bill requires the Food and Drug Administration (FDA) to publish an interim final rule implementing a provision of the Consolidated Appropriations Act of 2023 that authorized the use of certain alternatives to animal testing to support investigational use of a new drug.
The rule must replace references to animal tests, data, studies, models, and research with references to nonclinical tests, data, studies, models, and research throughout the FDA’s regulations governing investigational new drug applications.
The rule must be published within one year of the bill’s enactment, and must take immediate effect as an interim final rule.
Summary by the Congressional Research Service.
No recorded roll-call vote on this bill — it may have passed by voice vote or unanimous consent, which don't record individual votes.
- Jul 21, 2026Received in the Senate.
- Jul 20, 2026Motion to reconsider laid on the table Agreed to without objection.
- Jul 20, 2026On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H4639)
- Jul 20, 2026Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H4639)
- Jul 20, 2026DEBATE - The House proceeded with forty minutes of debate on H.R. 2821.
- Jul 20, 2026Considered under suspension of the rules. (consideration: CR H4639-4640)
- Jul 20, 2026Mr. Guthrie moved to suspend the rules and pass the bill.
- Jun 18, 2026Placed on the Union Calendar, Calendar No. 614.
- Jun 18, 2026Reported by the Committee on Energy and Commerce. H. Rept. 119-706.
- May 21, 2026Ordered to be Reported by the Yeas and Nays: 44 - 0.
- May 21, 2026Committee Consideration and Mark-up Session Held
- May 13, 2026Forwarded by Subcommittee to Full Committee by Voice Vote.
- May 13, 2026Subcommittee Consideration and Mark-up Session Held
- Apr 10, 2026Referred to the Subcommittee on Health.
- Apr 10, 2025Referred to the House Committee on Energy and Commerce.
- Apr 10, 2025Introduced in House